JOHESU Kicks as NAFDAC DG's Actions Driving High Cost of Drugs
JOHESU Kicks as NAFDAC DG’s Actions Driving High Cost of Drugs
Stay updated with breaking news from Stringent Regulatory Authorities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JOHESU Kicks as NAFDAC DG’s Actions Driving High Cost of Drugs
Starting January 2024, the Nigerian drug regulatory authority will only accept and review applications for product registration if they are supported by raw materials from approved sources
The National Agency for Food and Drug Administration and Control, NAFDAC, has announced stringent requirements for registering pharmaceutical products
When the Law on Pharma came into effect in 2016, most Indian pharma companies imported drugs from India and Europe into Vietnam. Some companies only registered drugs in Vietnam and transferred other Indian or Vietnamese pharma companies to sell.
The Ministry of Health has just issued Circular 08/2022/TT-BYT (“Circular 08”) stipulating the marketing authorization of drugs and medicinal ingredients to replace Circular...